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Abstract 
Palatability and variety of foods are major reasons for hedonic eating, and hence for 
obesity. Hemopressin, a hemoglobin  α chain-derived peptide, plays antagonist/inverse 
agonist role on cannabinoid (CB)1 receptors, while RVD-hemopressin(α)[RVD-hp(α)], 
a N-terminally extended form of hemopressin, has been reported as an allosteric 
modulator of CB1 and CB2 receptors.  
We investigated the effects of 14 daily intraperitoneal injections of RVD-hp(α), in 
Sprague-Dawley rats fed a highly palatable cafeteria-style (CAF) diet (30% fat, 56% 
carbohydrate, 14% protein; 4.20 kcal/g) compared to standard laboratory chow (STD) 
food (3.5% fat, 63% carbohydrate, 14% protein, 19.5% other components without 
caloric value; 3.20 kcal).  
Food intake, body weight and locomotor activity were recorded throughout the study. 
Finally, rats were sacrificed and agouti-related peptide (AgRP), neuropeptide Y (NPY), 
pro-opiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript 
(CART) gene expression in the hypothalamus was measured by real-time reverse 
transcription polymerase chain reaction.  
We found that CAF diet increased food intake as compared to STD diet. In both STD 
and CAF diet fed rats, RVD-hp(α) treatment inhibited food intake, increased locomotor 
activity but did not modify body weight. In vehicle injected animals, CAF as compared 
to STD diet increased AgRP mRNA gene expression. RVD-hp(α) treatment decreased 
POMC mRNA levels in both diet groups and lowered the elevated AgRP levels induced 
by CAF diet. 
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RVD-hp(α) treatment plays an anorexigenic role paralleled by increased locomotor 
activity both in STD and CAF diet fed rats. The inhibition of feeding could be partially 
mediated by lowering of hypothalamic POMC and AgRP gene expression levels. 
Keywords:  
RVD-hemopressin(α) 
Food intake 
Cafeteria diet 
 
Abbreviations: 
Agouti-related peptide (AgRP); Cafeteria diet (CAF); Cocaine- and amphetamine-
regulated transcript (CART); Cannabinoid 1 (CB1); Endocannabinoid (eCB);   fatty 
acid amide hydrolase (FAAH); Hemopressin (Hp); Neuropeptide Y (NPY); Pro-
opiomelanocortin (POMC); RVD-hemopressin(α) [RVD-hp(α)]; standard laboratory 
chow (STD); transient receptor potential vanilloid 1 (TRPV1).   
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1. Introduction 
The hypothalamus plays a pivotal role in the control of food intake and energy balance 
(Rui, 2013), while the hedonic aspects related to food intake are processed by 
corticolimbic reward pathways, particularly in the amygdala (Balleine et al., 2003). 
Overeating is stimulated by the abundance of food, particularly highly palatable, 
energy-rich food, such as sugar and chocolate (Balleine et al., 2003; Berthoud, 2004; De 
Castro and Stroebele, 2002; Rolls, 2003; Tordoff, 2002; Ulijasze, 2002). Palatability is 
reputed the most important non-homeostatic factor controlling food intake (Berthoud 
2004). Enhanced taste and flavor can elicit further food intake in satiated animals, and 
chronically lead to obesity (Sclafani, 1987; Warwick and Schiffman, 1992). Studies also 
point to palatable meal in inducing food addiction (Erlanson-Albertsson, 2005; 
Colantuoni et al., 2002; Gosnell and Krahn 1992; Nestle and Aghajanian, 1997). 
Actually, palatable food intake stimulates neuronal pathways that are also affected by 
abuse substances, such as alcohol and morphine (Volkow and Wise, 2005; Berridge, 
1996; Gosnell, 2000; Kelley et al., 2003). Endogenous cannabinoids and cannabinoid 
agonists have a well established role of appetite stimulators, by affecting mesolimbic 
and hypothalamic circuitries involved in feeding-related reward (Ramos et al., 2005, 
Balleine et al., 2003). In particular, CB1 antagonists and inverse agonists inhibit reward 
for sucrose pellets or chocolate-flavored food, blocking 
compulsive eating of palatable food in rats (Warwick and Schiffman, 1992; Droste et 
al., 2010; Dore et al., 2014). 
Hemopressin, a nonapeptide derived from the α1-chain of rat hemoglobin, and RVD-
hemopressin-(α) [RVD-hp(α)], a N-terminally extended form of hemopressin, bind to 
CB1 receptors, playing the role of antagonist/inverse agonist and negative allosteric 
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modulator, respectively (Heimann et al., 2007; Bauer et al., 2012; Han et al., 2014). On 
the other hand, both VD-hemopressin-(α) [VD-hp(α)], an other N-terminally extended 
hemopressin, and RVD-hp(α) were firstly reported as CB1 agonists in vitro (Gomes et 
al., 2009). In addition, in vivo, VD-hp(α) and RVD-hp(α) functioned as CB1 agonists 
(Han et al., 2014; Tanaka et al., 2014). Recent findings revealed that RVD-hp(α) 
behaved as a positive allosteric modulator of CB2 receptor (Petrucci et al., 2017). Han 
and collaborators (2014) reported that central injection of VD-hp(α) increased food 
intake and decreased locomotor activity in mice, consistently with its putative agonist 
CB1 activity. However, RVD-hp(α) has been reported to exert anorexigenic effects after 
both repeated peripheral and single central administration, in rats, which could be 
related, albeit partially, to its negative allosteric modulator activity on CB1 receptors 
(Ferrante et al, 2017; Recinella et al., 2018). In addition, we previously reported that 
RVD-hp(α) did not modify locomotor activity, after a single peripheral administration 
in rats (Leone et al., 2017). Anxiolytic/antidepressant effects have also been induced by 
RVD-hp(α), after both central and peripheral administration in rats (Dodd et al., 2010; 
Ferrante et al., 2017; Leone et al., 2017; Recinella et al., 2018). In the present work, we 
have further investigated the anorexigenic effects induced by RVD-hp(α) administration 
in rats fed a highly palatable cafeteria-style diet (CAF), compared to standard laboratory 
chow diet (STD). 
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2. Materials and methods 
2.1 Animals 
Male adult Sprague-Dawley rats (180-200 g, 7-8 weeks of age) were housed in 
Plexiglas cages (2 animals per cage; 40 cm × 25 cm × 15 cm) with a millboard changed 
every 12 h and maintained under standard laboratory conditions (22 ± 1 °C; 60% 
humidity), on a 12 h/12 h light/dark cycle (light phase: 07:00–19:00 h), with free access 
to tap water and food. Housing conditions and experimentation procedures were strictly 
in accordance with the European Community ethical regulations (EU Directive 
2010/63/EU) on the care of animals for scientific research. All the procedures were 
approved by local Ethical Committee of G. d’Annunzio University and by Italian 
Ministry of Health (Ministry authorization n. 880/24th August 2015).  
2.2 Experimental procedure  
After 1-week acclimatization, rats (n=48) were randomized to standard (STD) diet 
(n=24) or cafeteria (CAF) diet (n=24) for 14 days. STD diet rats were fed laboratory 
chow in pellets (3.5% fat, 63% carbohydrate,14% protein, 19.5% other components 
without caloric value; 3.20 kcal/g). CAF diet rats were given, in addition to the standard 
chow as above, cafeteria-style food (into two separate troughs), which included chips of 
parmigiano–reggiano cheese, potato chips, roasted, hazelnuts, cookies, curls of salt 
butter and bits of torrone chocolate, in the ratio 1:1:1:1:1:1:1 (in terms of grams). The 
average composition of CAF diet was: 30% fat, 56% carbohydrate, and 14% protein, 
4.20 kcal/g (Tab. 1) (Brunetti et al., 2009; Ottani et al., 2007). Both STD and CAF diet 
fed rats were divided into two groups of 12 animals each and injected daily for 14 days 
intraperitoneally, as previously described (Brunetti et al., 2009; Ottani et a., 2007), at 
9.00 am, during the light phase, with either vehicle (0.2 ml saline) or RVD-hp(α) (0.2 
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ml, 10 nmol/rat). RVD-hp(α) was diluted in saline and dosage was selected on the basis 
of previous studies (Dodd et al., 2010, 2013; Ferrante et al., 2017; Leone et al., 2017). 
Food intake (expressed in kilocalories) and body weight were recorded every 4 days 
throughout the study in all study groups. Food eaten through the whole period was 
recorded in each group of rats, by subtracting residual food in the dispenser and hick 
millboard from the food initially given. The cafeteria-style food has been weighed as 
single component. Soon after each injection, rectal temperature measurements were 
taken once every hour, over a five-hour period (10:00–15:00), by the insertion of a 
plastic-coated thermocouple into the rectum (pd 0331; Panlab, Barcelona, Spain) (0, 8, 
20, 28 days).  
24  h after the last RVD-hp(α) administration, the animals were sacriﬁced by CO2 
inhalation (100 % CO2 at a flow rate of 20 % of the chamber volume per minute). 
Fat depots were quickly excised and weighed, after animal sacrifice. Body fat content 
represents the total wet weight of retroperitoneal and epididymal fat normalized by body 
weight (g/100 g body weight). 
RVD-hp(α) has been synthetized and characterized in our laboratories, as previously 
reported (Mollica et al., 2013, 2015a and 2015b). 
2.3 Locomotor activity 
Immediately after each injection, locomotor activity in the home cage was recorded by a 
video camera positioned in the top-centre of the cage and connected to a computer, as 
previously reported (Leone et al., 2015). Separate video frames with a highly accurate, 
programmable, monochrome frame grabber board (DataTranslationTM, type DT3153). 
The apparatuses were purchased from 2 Biological Instruments (Besozzo VA, Italy). 
Intelligent software Smart version 2.5 (Panlab, sl Bioresearch and Technology, 
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Barcelona, Spain) was used for data processing, automatically recording distance 
travelled (cm), number of Z-beam breaks, for 10 min.  
2.4 RNA extraction, reverse transcription and real-time reverse transcription 
polymerase chain reaction (real-time RT PCR) 
Immediately after sacrifice, brains were collected and hypothalami rapidly removed 
[using the landmarks of the optic chiasm rostrally and the mammillary bodies caudally 
(Xu et al., 2011); coordinates of hypothalamus as follows: anteroposterior (AP), 2.06 
mm; mediolateral (ML), 0.2 mm; dorsoventral (DV), - 6.89 mm (Paxinos and Watson, 
2007)], dissected and stored in RNAlater solution (Ambion, Austin, TX) at −20 ◦C until 
further processed. Total RNA was extracted from the hypothalamus using TRI Reagent 
(Sigma-Aldrich, St. Louis, MO), as previously reported (Brunetti et al., 2014). One μg 
of total RNA extracted from each sample in a 20 μl reaction volume was reverse 
transcribed using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 
Foster City, CA, USA). Reactions were incubated in a 2720 Thermal Cycler (Applied 
Biosystems, Foster City, CA, USA) initially at 25°C for 10 min, then at 37°C for 120 
min, and finally at 85°C for 5 s. Gene expression was determined by quantitative real-
time PCR using TaqMan probe-based chemistry (Assays-on-Demand Gene Expression 
Products, Rn00567382_m1 for CART gene, Rn00595020_m1 for POMC gene, 
Rn01431703_g1 for AgRP gene, Rn00561681_m1 for NPY gene, Rn00577086_m1 for 
FAAH gene). β-actin (Applied Biosystems, Foster City, CA, USA, Part No. 4352340E) 
was used as the housekeeping gene. The real-time PCR was carried out in triplicate for 
each cDNA sample in relation to each of the investigated genes. Data were elaborated 
with the Sequence Detection System (SDS) software version 2.3 (Applied Biosystems, 
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Foster City, CA, USA).  Gene expression was relatively quantified by the comparative 
2-ΔΔCt method (Livak et al., 2001). 
2.5 In vitro studies: TRPV1 channel assay. 
HEK293 (human embryonic kidney) cells stably over-expressing recombinant human 
TRPV1 were grown on 100 mm diameter Petri dishes as mono-layers in minimum 
essential medium (EMEM) supplemented with non-essential amino acids, 10% foetal 
bovine serum, and 2 mM glutamine, and maintained at 5% CO2 at 37 °C. The effect of 
the substances on intracellular Ca2+ concentration ([Ca2+]i) was determined by using 
Fluo-4, a selective intracellular fluorescent probe for Ca2+ accordingly to Schiano and 
De Petrocellis (2016). Briefly, on the day of the experiment, cells were loaded at room 
temperature for 1 h with the methyl ester Fluo-4-AM (invitrogen) in EMEM, then 
washed twice in Tyrode’s buffer (145 mM NaCl, 2.5 mM KCl, 1.5 mM CaCl2, 1.2 mM 
MgCl2, 10mM D-glucose, and 10 mM HEPES, pH 7.4), resuspended in the same 
buffer, and transferred (about 100,000 cells) to the quartz cuvette of the 
spectrofluorimeter (Perkin-Elmer LS50B PerkinElmer Life and Analytical Sciences, 
Waltham, MA, USA) under continuous stirring. The changes in [Ca2+]i were determined 
before and after the addition of various concentrations of test compounds by measuring 
cell fluorescence (λex = 488 nm, λem = 516 nm) at 25 °C. Curve fitting (sigmoidal 
dose–response variable slope) and parameter estimation were performed with GraphPad 
Prism® (GraphPad Software Inc., San Diego, CA). Potency was expressed as the 
concentration of test substances exerting a half-maximal agonist effect (i.e. half-
maximal increases in [Ca2+]i) (EC50). The efficacy of the agonists was first determined 
by normalizing their effect to the maximum Ca2+ influx effect on [Ca2+]i observed with 
application of 4 μM ionomycin (Invitrogen).  
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2.6 Statistical analysis 
Statistical analysis was performed using GraphPad Prism version 5.01 for Windows 
(GraphPad Software, San Diego, CA, USA). Food intake (kcal), body weight (g) and 
locomotor activity data were collected from each of the  animals used in the 
experimental procedure and means ± S.E.M. were determined for each experimental 
group and analyzed by two way analysis of variance (ANOVA) followed by Bonferroni 
post-hoc test.  Gene expression data were collected from each of the  animals used in 
the experimental procedure and means ± S.E.M. were determined for each experimental 
group and analyzed by one way analysis of variance (ANOVA) followed by Bonferroni 
post-hoc test. As for gene expression analysis, 1.00 (calibrator sample) was considered 
the theoretical mean for the comparison. Statistical significance was accepted at p < 
0.05, p < 0.005 and p < 0.001. As regards to the animals randomized for each 
experimental group, the number was calculated on the basis of the “Resource Equation” 
N=(E+T)/T (10≤E≤20), where E, N and T represent the number of degrees of freedom 
in an ANOVA, animals and treatments, respectively (Charan and Kantharia, 2013). 
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3. Results 
Figures 1 and 2 (see also Tables 2 and 3 reporting means ± S.E.M.) show food intake 
recorded every 4 days and mean daily food intake expressed in kilocalories (kcal), 
respectively, in rats fed with either STD or CAF diet, and treated with vehicle or RVD-
hp(α). The caloric intake in animals fed with CAF diet is significantly higher [F4/13 = 
3.18; p = 0.001] with respect to STD rats. RVD-hp(α) (10 nmol) treatment induced 
inhibition of food intake in both STD [F11/5 = 3.33; p = 0.003] and CAF [F6/8 = 3.58; p = 
0.04] animals, since day 12 and day 20, respectively. As for CAF diet, we observed that 
RVD-hp(α) treatment did not modify the chow/mixture ratio as compared to CAF-
vehicle (Figure 3). 
On the other hand, we found that the effect was weaker in CAF rats [F5/16 = 2.85; p = 
0.003].  
Figures 4 and 5 (see also Tables 4 and 5 reporting means ± S.E.M.) show body weight 
recorded every 4 days and body weight gain expressed in grams, respectively, in rats fed 
with either STD or CAF diet, and treated with vehicle or RVD-hp(α). Independently of 
treatment, CAF rats had increased body weight gain [F7/11 = 3.01; p = 0.000] as 
compared to STD rats, while RVD-hp(α) treatment did not modify body weight in both 
CAF and STD groups. Moreover, we evaluated fat mass (g/100 g body weight) in rats 
fed with either STD or CAF diet, and treated with vehicle or RVD-hp(α), finding a 
significant increase in CAF animals compared to STD [fat mass (g/100 g body weight): 
means ± S.E.M., STD-vehicle 10.0 ± 0.7; CAF-vehicle 13.76 ± 0.1, F 8/19 = 2.48; p = 
0.005]. On the other hand, we have not found any difference between STD-RVD-hp(α) 
and CAF- RVD-hp(α). 
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Additionally, no difference in rectal body temperature was also found in rats fed with 
either STD or CAF diet, and treated with vehicle or RVD-hp(α). [body temperature: 
means ± S.E.M., Day 0: STD-vehicle 37.65 ± 0.20; CAF-vehicle 37.43 ± 0.22; STD-
RVD-hp(α) 38.20 ± 0.23; CAF- RVD-hp(α) 37.80 ± 0.22; Day 8: STD-vehicle 37.65 ± 
0.20; CAF-vehicle 37.43 ± 0.22; STD-RVD-hp(α) 38.20 ± 0.23; CAF- RVD-hp(α) 
37.80 ± 0.22; Day 20: STD-vehicle 38.50 ± 0.34; CAF-vehicle 37.90 ± 0.13; STD-
RVD-hp(α) 37.75 ± 0.37; CAF- RVD-hp(α) 38.23 ± 0.39; Day 28: STD-vehicle  38.20 
± 0.17; CAF-vehicle 38.10 ± 0.03; STD-RVD-hp(α) 37.90 ± 0.11; CAF- RVD-hp(α) 
38.03 ± 0.11]. 
In vehicle injected animals, despite increased caloric intake in CAF animals, we did not 
observed any effect of CAF vs. STD diet on locomotor activity. Moreover, we found 
that RVD-hp(α) treatment induced a significant increase of horizontal and vertical 
activity [F3/18 = 3.16; p = 0.002; F 5/16 = 2.85; p = 0.003] both in STD and CAF diet rats 
(Fig. 6) (see also Table 6 reporting means ± S.E.M.).  
In the hypothalamus of vehicle treated animals, CAF diet resulted in increased AgRP 
mRNA levels and no significant differences in CART, POMC and NPY gene 
expression levels, as compared to STD diet. In STD rats, RVD-hp(α) treatment inhibited 
POMC gene expression, with no effects on CART, AgRP and NPY mRNA levels. In 
CAF rats, RVD-hp(α) treatment also inhibited POMC gene expression. Interestingly, 
the elevated AgRP mRNA levels found in CAF rats injected with vehicle were lowered 
by RVD-hp(α) treatment [F2/23 = 3.42; p = 0.001] (Fig. 7; see also Table 7 reporting 
means ± S.E.M.). Also, in CAF rats CART and NPY mRNA levels were not affected by 
RVD-hp(α) (Fig. 5). 
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Finally, we observed that RVD-hemopressin(α) was able to induce intracellular Ca2+ 
elevation in HEK293 cells stably transfected with the human TRPV1 cDNAs. The 
calcium influx was expressed as percentage response (21± 0.5 %), compared to the Ca2+ 
ionophore ionomycin 4 μM. The related EC50 value was 32.6 ± 2.5 μM. Five minute 
preincubation of human TRPV1-HEK293 cells with the strong TRPV1 antagonist 5-
iodoresiniferatoxin (0.1 μM), had no effect at all on RVD-hemopressin(α) response 
(Fig. 8). On the other hand, we cannot exclude that Ca2+ influx, although not TRPV1-
dependent, could however induce the synthesis on demand of anandamide. To explore 
this hypothesis we evaluated the effect of the peptide on anandamide metabolism, in 
vivo. We found that peptide injection decreased FAAH gene expression in the 
hypothalamus (Fig. 9).  
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4. Discussion 
Increased availability of highly palatable food is considered a major contributor to 
eating disorders and obesity. A highly palatable diet induces a spontaneous and 
progressively increasing hyperphagia and body weight gain in animals (Judge et al., 
2008), which could be modulated by endogenous cannabinoids (Lau et al., 2017).  
As expected, we found that in CAF diet fed rats the caloric intake was significantly 
higher compared to STD diet, paralleled by an increase in body weight gain. Our 
present findings show that CAF diet is attractive for rats and mimicks conditions 
leading to overfeeding in humans. 
RVD-hp(α) treatment inhibited food intake both in STD and CAF diet rats, but the 
effect was weaker in latter. We can speculate that the more palatable CAF diet can drive 
macronutrient selection toward more energy dense food, blunting the anorectic effect of 
RVD-hp(α). Similar effects were reported for other anorexigenic substances such as 
obestatin, tested in CAF vs. STD diet fed animals (Brunetti et al., 2009). Although 
inducing decreased caloric intake, RVD-hp(α) treatment did not modify body weight, 
which could probably relate to decreased uncoupling protein 1 (UCP-1) gene expression 
in brown adipose tissue and consequent reduction of thermogenic energy expenditures 
in RVD-hp(α) treated animals  (Ferrante et al., 2017). 
Also, we did not observed any effect of CAF vs. STD diet on locomotor activity, as 
reported by da Costa Estrela and collaborators (2015). However, we found increased 
locomotor activity induced by RVD-hp(α) treatment both in STD and CAF animals. 
Increased locomotion was reported for cannabidiol, which is also a CB1 receptor 
negative allosteric modulator, and stimulates locomotor activity in animal models 
(Britch et al., 2017).  
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Interestingly, the increased energy expenditure induced by locomotion could counter the 
inhibitory effect on uncoupling protein 1 (UCP-1) gene expression in brown adipose 
tissue following RVD-hp(α) administration (Ferrante et al., 2017), explaining the 
observed null effect of RVD-hp(α) on body weight. The lack of any effect on body 
temperature is in agreement with the downregulation of UCP-1 gene expression 
following peptide administration (Ferrante et al., 2017). 
If, on one side, we can’t exclude that the acute increase in locomotor activity is 
followed by a significant decrease in locomotion in later time points, on the other hand, 
the only way to determine the underlying cause of the lack of weight change is to 
measure energy expenditure. The lack on body weight change following RVD-hp(α) 
administration could indicate a minor role displayed by the peptide on obesity therapy. 
Nevertheless, the antidepressant and anti-anxiety effects found in our previous studies 
(Leone et al., 2017; Recinella et al., 2018) are an intriguing result that could account for 
further deepenings. 
The observed effects induced by CAF diet and RVD-hp(α) treatment could be mediated 
by modifications of neuropeptide levels in the hypothalamus. In vehicle treated animals, 
the finding of increased feeding induced by CAF diet could be related to elevated AgRP 
mRNA levels in the hypothalamus, as compared to vehicle injected animals. AgRP 
plays a well established role in stimulating feeding. Previous studies reported that AgRP 
injection increased the intake of a palatable diet, possibly through the modulation of 
pre-ingestive factors, such as taste and palatability, or post-ingestive factors such as gut 
peptide release (Tracy et al., 2007). Also, Lazzarino and collaborators (2017) observed, 
in rats fed a CAF diet, increased AgRP gene expression in the ventromedial and 
paraventricular hypothalamus with a concomitant reduction of AgRP gene expression in 
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arcuate nucleus. On the other hand, we observed that treatment of CAF rats with RVD-
hp(α) resulted in lowering of the elevated AgRP mRNA to levels found in STD animals, 
partially explaining the anorexigenic effects induced by the peptide. 
A further mechanistic effect underlying decreased feeding induced by RVD-hp(α) is the 
observed inhibition  of  hypothalamic POMC gene expression in both STD and CAF 
animals. Recent studies suggest that the orexigenic effects of endocannabinoids could 
be mediated by increased POMC-derived β-endorphin (Bakkali-Kassemi et al., 2011). 
The negative allosteric modulation of CB1 receptors induced by RVD-hp(α) could 
induce anorexigenic effects, both in STD and CAF rats, through reduced β-endorphin 
levels consequent to inhibited POMC gene expression. In this context, the reduction of 
POMC gene expression, despite appearing paradoxical, is in agreement with the 
interaction of RVD-hp(α) with CB1 receptor. Previous studies indicated that feeding 
stimulating effects induced by CB1 agonists could involve the stimulation of POMC 
signaling (Koch et al., 2015). Additionally, our previous study on the effect of RVD-
hp(α) on lean rat fed a STD diet displayed a reduction of POMC gene expression 
(Ferrante et al., 2017). Actually, this could be related to the capability of POMC gene to 
encode for two peptides, α-MSH and β-endorphin, exerting opposite effects on feeding. 
On the other hand, CART and NPY gene expressions seem not be involved in the 
effects on feeding induced by CAF diet or RVD-hp(α) treatment. 
In addition, as regards the receptor mechanism at the basis of the observed effects, we 
also explored the possibility that RVD-hp(α) could modulate transient receptor potential 
vanilloid 1 (TRPV1) activity, as suggested by Fogaça (2015). The negative results 
obtained in vitro in our laboratory (data reported in the file:Supplementary data- in 
vitro and in vivo studies) indicated that RVD-hp(α) does not directly activate TRPV1 
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signaling. On the other hand, the blunting effect on hemopressin pharmacological 
activity induced by co-treatment with TRPV1 antagonists (Fogaça et al., 2015) supports 
a stimulation of this signaling induced by the peptide. At confirmation of this 
hypothesis, we performed subsequent in vitro studies on HEK293 (human embryonic 
kidney) cells stably over-expressing recombinant human TRPV1 treated with RVD-
hp(α). The tested peptide, despite increasing Ca2+ influx in HEK293 cell line, does not 
seem to be directly involved in TRPV1 activation. On the other hand, a Ca2+ influx, 
although not TRPV1-dependent, could however induce the synthesis on demand of 
anandamide (Di Marzo et al., 2001; Smart et al., 2000; Zygmunt et al., 2000). To this 
regard, we performed a further analysis of the pattern of gene expression altered by 
peptide injection, finding a significant inhibition of fatty acid amide hydrolase (FAAH) 
gene expression. FAAH is a key enzyme involved in the degradation of 
endocannabinoids such as anandamide. Anandamide, besides being the principle 
endocannabinoid, is also the principle endovanilloid molecule. So, our findings of 
inhibition of FAAH gene expression following peptide treatment, further support the 
involvement of anandamide in mediating RVD-hp(α) effects in vivo. 
In conclusion, RVD-hp(α) treatment plays an anorexigenic role paralleled by increased 
locomotor activity both in STD and CAF diet fed rats. The inhibition of food intake 
could be partially mediated by lowering of POMC and AgRP gene expression levels in 
the hypothalamus. 
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Legends to figures and table 
 
Fig. 1. Effects of CAF diet and chronic administration RVD-hp(α) (10 nmol) on daily 
food intake (kcal), recorded every 4 days, in CAF diet fed rats.  Rats (n=48) were 
randomized to standard (STD) diet (n=24) or cafeteria (CAF) diet (n=24) for 14 days, 
then 14 days treatment with RVD-hp(α) (10 nmol) (n = 12 for each experimental 
group).  Values represent the means ± S.E.M. (** p < 0.005 vs. STD-vehicle; * p < 0.05 
vs. CAF-vehicle; # p < 0.001 vs. STD-vehicle). 
 
Fig. 2. Effects of CAF diet and chronic administration RVD-hp(α) (10 nmol) on the 
mean daily food intake (kcal) in CAF diet fed rats (n = 12 for each experimental group).  
Values represent the means ± S.E.M. (** p < 0.005; *** p < 0.001 vs. STD-vehicle; * p 
< 0.05 vs. CAF-vehicle).  
 
Fig. 3: Effects of CAF diet and chronic administration RVD-hp(α) (10 nmol) on daily 
food intake (kcal). The kilocalories were separately calculated for both standard chow  
and mixture of chips of parmigiano–reggiano cheese, potato chips, roasted, hazelnuts, 
cookies, curls of salt butter and bits of torrone chocolate. Values represent the means ± 
S.E.M. (* p < 0.05 vs. CAF-vehicle).  
 
Fig. 4. Effects of CAF diet and chronic administration RVD-hp(α) (10 nmol) on daily 
body weight (g), recorded every 4 days, in CAF diet fed rats. Rats (n=48) were 
randomized to standard (STD) diet (n=24) or cafeteria (CAF) diet (n=24) for 14 days, 
then 14 days treatment with RVD-hp(α) (10 nmol) (n = 12 for each experimental 
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group).  Values represent the means ± S.E.M. [* p < 0.05; *** p < 0.001 vs. STD-
vehicle and STD- RVD-hp(α)]. 
 
Fig. 5. Effects of CAF diet and chronic administration RVD-hp(α) (10 nmol) on the 
body weight gain (%) in CAF diet fed rats (n = 12 for each experimental group). Values 
represent the means ± S.E.M. [*** p < 0.001 vs. STD-vehicle and STD- RVD-hp(α)]. 
 
Fig. 6. RVD-hp(α) (10 nmol) significantly increased locomotor activity in  STD and 
CAF diet fed rats (n = 12 for each experimental group). Horizontal activity and vertical 
activity were recorded for 10 min. Values represent the means ± S.E.M. (** p < 0.005 
vs. STD- and CAF-vehicle). 
 
Fig. 7. Relative gene expression of hypothalamic neuropetides after RVD-hp (α) (10 
nmol) administration in STD and CAF diet fed rats (n = 12 for each experimental 
group), as determined by real-time RT-PCR. Data were calculated using the 2-ΔΔCt 
method, normalized to β-actin mRNA levels, and expressed as relative to control 
(calibrator sample, defined as 1.00). Values represent the means ± S.E.M. (** p < 0.005 
vs. CAF-vehicle). 
 
Fig. 8. Effects of RVD-hp (α) (1-100 µM) on TRPV1 channel activity in HEK293 cell 
line. 
 
Fig. 9: Relative gene expression of hypothalamic FAAH after RVD-hp (α) (10 nmol) 
administration in STD diet fed rats (n = 12 for each experimental group), as determined 
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by real-time RT-PCR. Data were calculated using the 2-ΔΔCt method, normalized to β-
actin mRNA levels, and expressed as relative to control (calibrator sample, defined as 
1.00). Values represent the means ± S.E.M. (** p < 0.01 vs. vehicle treated group). 
 
Tab. 1. The numbers indicate the percentage in fat, carboidrates and protein of STD and 
CAF diet. 
 
Tab. 2: Effects of CAF diet and chronic administration RVD-hp(α) (10 nmol) on daily 
food intake (kcal), recorded every 4 days, in CAF diet fed rats. Rats (n=48) were 
randomized to standard (STD) diet (n=24) or cafeteria (CAF) diet (n=24) for 14 days, 
then 14 days treatment with RVD-hp(α) (10 nmol) (n = 12 for each experimental 
group). Values represent the means ± S.E.M. (# p < 0.005 vs. STD-vehicle; * p < 0.05 
vs. CAF-vehicle; # p < 0.001 vs. STD-vehicle). 
 
Tab.3: Effects of CAF diet and chronic administration RVD-hp(α) (10 nmol) on the 
mean daily food intake (kcal) in CAF diet fed rats (n = 12 for each experimental group).  
Values represent the means ± S.E.M. (** p < 0.005; *** p < 0.001 vs. STD-vehicle; * p 
< 0.05 vs. CAF-vehicle). 
 
Tab. 4: Effects of CAF diet and chronic administration RVD-hp(α) (10 nmol) on daily 
body weight (g), recorded every 4 days, in CAF diet fed rats. Rats (n=48) were 
randomized to standard (STD) diet (n=24) or cafeteria (CAF) diet (n=24) for 14 days, 
then 14 days treatment with RVD-hp(α) (10 nmol) (n = 12 for each experimental 
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group).  Values represent the means ± S.E.M. [* p < 0.05; *** p < 0.001 vs. STD-
vehicle and STD- RVD-hp(α)]. 
 
Tab. 5: Effects of CAF diet and chronic administration RVD-hp(α) (10 nmol) on the 
body weight gain (%) in CAF diet fed rats (n = 12 for each experimental group). Values 
represent the means ± SEM. [*** p < 0.001 vs. STD-vehicle and STD- RVD-hp(α)]. 
 
Tab. 6: RVD-hp(α) (10 nmol) significantly increased locomotor activity in  STD and 
CAF diet fed rats (n = 12 for each experimental group). Horizontal activity and vertical 
activity were recorded for 10 min. Values represent the means ± S.E.M. (** p < 0.005 
vs. STD- and CAF-vehicle). 
 
Tab. 7: Relative gene expression of hypothalamic neuropetides after RVD-hp (α) (10 
nmol) administration in STD and CAF diet fed rats (n = 12 for each experimental 
group), as determined by real-time RT-PCR. Data were calculated using the 2-ΔΔCt 
method, normalized to β-actin mRNA levels, and expressed as relative to control 
(calibrator sample, defined as 1.00). Values represent the means ± S.E.M. (** p < 0.005 
vs. CAF-vehicle). 
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Table 1. Composition of STD and CAF diet 
Component STD diet 
3.20 Kcal/g 
CAF diet 
4.20 Kcal/g 
 % % 
Fat 3  30 
Satured 22.72 45 
Insatured 77.27 55 
Carbohydrates 63 56 
Protein 14 14 
Other components without 
caloric value 
19.5 - 
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Table 2. Food intake (kcal) 
Day 0 4 8 12 16 20 24 28 
 Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
STD-vehicle 78.72±1,0 75.52±1.0 77.76±2.1 75.84±1.2 78.72±1.4 78.08±1.3 75.52±1.0 81.6±1.1 
STD-RVD-
hp(α)   
77.44±1.2 75.52±0.9 78.72±1.0 61.12±1.0
**
 58.88±1.2
**
 63.04±1.1
**
 60.8±0.6
**
 57.6±1.0
**
 
CAF-vehicle 100.8±0.4
#
 100.8±1.0
#
 102.9±1.2
#
 103.32±1.1
#
 99,12±1.2
#
 103,32±1.1
#
 107,52±1.2
#
 105±1.1
#
 
CAF-RVD-
hp(α) 
99,96±0.1
#
 99,96±1.2
#
 103,32±0.4
#
 99,12±1.2
#
 94,92±1.3
#
 94,08±1.0
#*
 90,72±1.1
#*
 92,4±1.4
#*
 
 
 
 
Table 3. Food intake (kcal) 
 STD diet CAF diet 
 Means ±S.E.M Means ±S.E.M 
Vehicle  78.72±2.8 103.32±1.8 
RVD-hp(α)   57.6±3.8** 96.18±1.9* 
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Table 4. Body weight (g) 
Day 0 4 8 12 16 20 24 28 
 Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
Means 
±S.E.M. 
STD-vehicle 189.2±2.0 210.5±2.0 217.0±1.1 226±1.2 235.8±1.0 246.4±1.1 258.6±1.0 271.8±1.1 
STD-RVD-hp(α)   200.1±1.2 218.1±0.8 225.5±1.0 235.1±1.0 245.0 ±2.0 255.7±1.3 268.4±0.6 282.0±1.0 
CAF-vehicle 200.8±0.4 230.8±1.3 249.9±1.2 272.7±1.6 299.5±1.0
*
 330,4±1.2
**
 365.3±1.0
**
 408.1±1.1
***
 
CAF-RVD-hp(α) 220.3±0.7 236.4±1.0 258.9±1.4 282.6±1.2 310.3±1.3
*
 342.3±1.0
**
 378.2±1.2
**
 424.1±10
***
 
 
 
 
 
 
Table 5. Body weight gain (%) 
 STD diet CAF diet 
 Means ±S.E.M Means ±S.E.M 
Vehicle  16.86±3.8 33.1±2.8
***
 
RVD-hp(α)   16.84±3.9 34.1±2.7*** 
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Table 6. Locomotor activity 
 Horizontal Activity Vertical Activity 
 Means ±S.E.M Means ±S.E.M 
STD-vehicle 1230.0±46.8 31.0±3.8 
STD-RVD-hp(α)   1380.0±20.8
**
 35.2±2.0
**
 
CAF-vehicle 1130.3±50.8 28.2±2.9 
CAF- RVD-hp(α) 1350.1±34.0
**
 33.1±3.9
**
 
 
 
 
 
 
Table 7. Relative gene expression 
 
STD-vehicle STD-RVD-hp(α)  CAF-vehicle  CAF- RVD-hp(α) 
 
Means ±S.E.M. Means ±S.E.M. Means ±S.E.M. Means ±S.E.M. 
CART 
1.00±0.0 1.10±0.1 1.09±0.5 1.08±0.1 
POMC 
1.00±0.0 0.38±0.0
**
 0.98±0.1 0.56±0.2 
AGRP 
1.00±0.0 1.15±0.1 1.80±0.6
**
 0.98±0.3 
NPY 
1.00±0.0 1.00±0.2
**
 1.05±0.2
**
 0.90±0.1 
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 In both STD and CAF diet rats, RVD-hp(α) treatment inhibited food intake. 
       RVD-hp(α) treatment did not modify body weight in both CAF and STD groups. 
       RVD-hp(α) treatment increased locomotor activity in both STD and CAF diet 
rats. 
       RVD-hp(α) treatment decreased POMC gene expression in both STD and CAF 
rats.  
       RVD-hp(α) treatment lowered the elevated AgRP levels induced by CAF diet. 
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